SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
Deals
Sanofi Chief Says No Reason To Up Aventis Bid
October 19, 2005
 · 
1 min read
Deals
U.S. FTC Extends Aventis Rhodia Sale Deadline
October 19, 2005
 · 
1 min read
Deals
Aventis Lists Candidates For Merger
October 19, 2005
 · 
1 min read
Deals
Europe Abuzz With Drug Merger Talk
October 19, 2005
 · 
1 min read
Deals
L’Oreal To Meet Over Sanofi Bid For Aventis
October 19, 2005
 · 
1 min read
Genetown
Docetaxel Lowers Death Rate For Breast Cancer
October 19, 2005
 · 
1 min read
Deals
Aventis, Sanofi Shares Gain On Mounting Merger Talk
October 19, 2005
 · 
1 min read
Study Backs Therapy Over Sleeping Pills
October 19, 2005
 · 
1 min read
Policy
Doubts Over “Metabolic Syndrome” Weigh On Sanofi
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
December 29, 2025
 · 
5 min read
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
 · 
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
 · 
11 min read
Press Releases
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
December 24, 2025
 · 
9 min read
Press Releases
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
 · 
23 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 23, 2025
 · 
14 min read
Press Releases
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
December 22, 2025
 · 
7 min read
Press Releases
Press release: Availability of the Q4 2025 Aide memoire
December 17, 2025
 · 
4 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
 · 
6 min read
Press Releases
ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer’s Disease Therapy
December 16, 2025
 · 
2 min read
Load More